Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

AC Immune has amended its collaboration agreement with Eli Lilly [...]

Insilico Medicine has signed a drug discovery collaboration with Eli [...]

Long-term VIVID-2 data show more than 90% of patients with [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Eli Lilly and Company has launched TuneLab, a new artificial [...]

Lilly has voiced strong support for the US administration’s goal [...]

Mirikizumab is now recommended by NICE for routine NHS use [...]